Quarterly report pursuant to Section 13 or 15(d)

Note 6 - Stockholders' Deficit - Stock Options (Details)

v3.19.1
Note 6 - Stockholders' Deficit - Stock Options (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2018
Outstanding, Number of Shares (in shares) 2,235,000  
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 1.74  
Outstanding, Weighted Average Remaining Life (Year) 7 years 335 days 9 years 160 days
Outstanding, Aggregate Intrinsic Value $ 16,767,663 $ 23,100
Granted, Number of Shares (in shares) 401,750  
Granted, Weighted Average Exercise Price (in dollars per share) $ 1.75  
Outstanding, Number of Shares (in shares) 2,636,750 2,235,000
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 1.74 $ 1.74
Exercisable, Number of Shares (in shares) 7,500  
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 0.13  
Exercisable, Weighted Average Remaining Life (Year) 8 years 186 days  
Exercisable, Aggregate Intrinsic Value $ 59,775